ABBV
Price:
$179.8
Market Cap:
$317.73B
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pan...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2013-01-02
Stock Exchange
NYSE
Ticker
ABBV
According to AbbVie Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 62.65. This represents a change of -0.78% compared to the average of 63.14 of the last 4 quarters.
The mean historical PE Ratio of AbbVie Inc. over the last ten years is 30.53. The current 62.65 PE Ratio has changed 20.42% with respect to the historical average. Over the past ten years (40 quarters), ABBV's PE Ratio was at its highest in in the December 2020 quarter at 1.32K. The PE Ratio was at its lowest in in the June 2020 quarter at -54.66.
Average
30.53
Median
24.58
Minimum
16.64
Maximum
58.84
Discovering the peaks and valleys of AbbVie Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 189.43%
Maximum Annual PE Ratio = 58.84
Minimum Annual Increase = -68.19%
Minimum Annual PE Ratio = 16.64
Year | PE Ratio | Change |
---|---|---|
2023 | 56.34 | 132.99% |
2022 | 24.18 | 16.46% |
2021 | 20.76 | -46.34% |
2020 | 38.70 | 132.60% |
2019 | 16.64 | -33.40% |
2018 | 24.98 | -14.08% |
2017 | 29.07 | 70.40% |
2016 | 17.06 | -8.83% |
2015 | 18.71 | -68.19% |
2014 | 58.84 | 189.43% |
The current PE Ratio of AbbVie Inc. (ABBV) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
33.76
5-year avg
31.32
10-year avg
30.53
AbbVie Inc.’s PE Ratio is greater than Merck & Co., Inc. (20.73), greater than Pfizer Inc. (35.53), less than Eli Lilly and Company (85.65), greater than Bristol-Myers Squibb Company (-16.14), greater than Johnson & Johnson (23.91), greater than Amgen Inc. (33.58), less than Gilead Sciences, Inc. (929.81),
Company | PE Ratio | Market cap |
---|---|---|
20.73 | $251.57B | |
35.53 | $151.34B | |
85.65 | $755.34B | |
-16.14 | $117.15B | |
23.91 | $351.15B | |
33.58 | $142.17B | |
929.81 | $117.09B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AbbVie Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AbbVie Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is AbbVie Inc.'s PE Ratio?
How is the PE Ratio calculated for AbbVie Inc. (ABBV)?
What is the highest PE Ratio for AbbVie Inc. (ABBV)?
What is the 3-year average PE Ratio for AbbVie Inc. (ABBV)?
What is the 5-year average PE Ratio for AbbVie Inc. (ABBV)?
How does the current PE Ratio for AbbVie Inc. (ABBV) compare to its historical average?